Oliver Luxxe Assets LLC Has $797,000 Holdings in Walgreens Boots Alliance Inc (WBA)
Oliver Luxxe Assets LLC raised its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,322 shares of the pharmacy operator’s stock after acquiring an additional 1,039 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Walgreens Boots Alliance were worth $797,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the business. Commonwealth Bank of Australia grew its holdings in shares of Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after purchasing an additional 26,893 shares during the period. IBM Retirement Fund grew its holdings in shares of Walgreens Boots Alliance by 88.1% during the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock worth $2,004,000 after purchasing an additional 10,729 shares during the period. Andra AP fonden lifted its stake in Walgreens Boots Alliance by 35.3% during the 2nd quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock worth $4,565,000 after acquiring an additional 15,200 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 5.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after acquiring an additional 154,995 shares in the last quarter. Finally, Birinyi Associates Inc. lifted its stake in Walgreens Boots Alliance by 9.0% during the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after acquiring an additional 750 shares in the last quarter. 61.41% of the stock is owned by institutional investors.
In other news, Director John Anthony Lederer purchased 20,000 shares of the firm’s stock in a transaction on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.
A number of research firms have issued reports on WBA. Deutsche Bank began coverage on Walgreens Boots Alliance in a research report on Monday, December 4th. They issued a “hold” rating and a $78.00 price target on the stock. Vetr lowered Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 1st. Needham & Company LLC reduced their price target on Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research report on Wednesday, November 22nd. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Finally, Citigroup dropped their price target on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, November 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have assigned a buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $86.47.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $71.55 on Monday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00. The firm has a market capitalization of $70,859.95, a PE ratio of 14.03, a PEG ratio of 1.28 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. During the same quarter in the prior year, the firm posted $1.07 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% compared to the same quarter last year. research analysts expect that Walgreens Boots Alliance Inc will post 5.54 EPS for the current fiscal year.
Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board believes its shares are undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 42.33%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.